Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Med Biogene Inc (TSE:MBI.H)
TSXV:MBI.H
Med Biogene (MBI.H) Stock Price & Analysis
3 Followers
MBI.H Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week Range<C$0.01 - C$0.15
Previous CloseC$0.02
Volume1.50K
Average Volume (3M)10.23K
Market Cap
C$258.87K
Enterprise ValueC$257.46K
Total Cash (Recent Filing)$1.02K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-1.53
Next Earnings
Aug 23, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding17,257,838
10 Day Avg. Volume1,100
30 Day Avg. Volume10,226
Standard Deviation0.86
R-Squared0.00046
Alpha0.15
Financial Highlights & Ratios
Price to Book (P/B)-1.43
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-17.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.52
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
77.43% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
22.57% Public Companies and
Individual Investors
MBI.H FAQ
What was Med Biogene Inc’s price range in the past 12 months?
Med Biogene Inc lowest stock price was <C$0.01 and its highest was C$0.15 in the past 12 months.
What is Med Biogene Inc’s market cap?
Currently, no data Available
When is Med Biogene Inc’s upcoming earnings report date?
Med Biogene Inc’s upcoming earnings report date is Aug 23, 2024 which is in 28 days.
How were Med Biogene Inc’s earnings last quarter?
Currently, no data Available
Is Med Biogene Inc overvalued?
According to Wall Street analysts Med Biogene Inc’s price is currently Overvalued.
Does Med Biogene Inc pay dividends?
Med Biogene Inc does not currently pay dividends.
What is Med Biogene Inc’s EPS estimate?
Med Biogene Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Med Biogene Inc have?
Med Biogene Inc has 17,257,837 shares outstanding.
What happened to Med Biogene Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Med Biogene Inc?
Currently, no hedge funds are holding shares in TSE:MBI.H
---
Med Biogene Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.12%
Trailing 12-Months
Company Description
Med Biogene Inc
Med Biogene Inc is a Canada based life science company. It is primarily focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests. The company is engaged in managing the license and rights to GeneFx Lung, which is a proprietary gene expression-based test for identifying those patients with early-stage non-small-cell lung cancer.
---
Technical Analysis
---